Cancer Center A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Medulloblastoma"

Drug Intervention Trials that are Recruiting

Study Title
Principal Investigator Disease Category
A Study of Pemetrexed in Children With Recurrent Cancer Dr. Neyssa Maria Marina
Osteosarcoma
Neuroblastoma
Medulloblastoma
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Dr. Neyssa Marina
Central Nervous System Neoplasms
Brain Cancer
Medulloblastoma
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma Paul Graham Fisher
Central Nervous System Neoplasms
Brain Cancer
Neuroectodermal Tumors
Medulloblastoma



Trials not Recruiting

Study Title
Principal Investigator Disease Category
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting)
Dr. Neyssa Marina
Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: